Consumption History Safety Sativa 
SpeedWeed
MARCH 21, 2021
As is the case in the United States, Europe lacks sufficiently reliable scientific data to support the safety of products infused with full spectrum hemp extract. In January 2019, the European Union (EU) reclassified extracts of cannabis sativa L. Read the entire article at The Fresh Toast. View original article.
Cannabis Law Report
APRIL 14, 2019
The Spanish Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN) has struck a blow against hemp food producers in their ongoing efforts to clear a path for hemp extracts in food across Europe. The Catalogue is essentially a food safety mechanism. Language in rules affecting CBD, updated Jan. Agency’s warning.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TheAnswerPage
FEBRUARY 25, 2022
Cannabis sativa – One plant, Many crops. Despite its cultivation as a source of food, fiber and medicine, and its global status as the most frequently used illicit drug, plants in the genus Cannabis currently experience an inconclusive taxonomic organization and evolutionary history. More on potency will be discussed in future blogs.
Canna Law Blog
MARCH 26, 2020
Last year, the European Union reclassified extracts of Cannabis sativa L. The reclassification was based on the lack of demonstrated history of human consumption of these extracts and of any product to which they might be added. Phase 2 – Safety Assessment.
Canna Law Blog
FEBRUARY 14, 2019
The European Food Safety Authority (“ EFSA ”), the European equivalent of the U.S. extracts of Cannabis sativa L. and derived products containing cannabinoids are considered novel foods as a history of consumption has not been demonstrated. extracts of Cannabis sativa L.
Cannabis Law Report
AUGUST 12, 2019
It was announced in January 2019 that the European Food Safety Association, EFSA is about to make a decision in order to classify CBD oil and other CBD products as a novel food. In other words, we can say that Novel foods are those foods which don’t have a proper and significant history of consumption.
Cannabis Law Report
JUNE 21, 2021
In the medical cannabis industry, mostly due to the plant’s long history of prohibition, there is a decided lack of data regarding the use and efficacy of cannabis as a treatment for a wide variety of indications. Indicas accounted for about 46% of use, sativas about 33%, and hybrids 21%. RYAH Group Inc. The Upshot.
Expert insights. Personalized for you.
52 
Let's personalize your content